IB Net Payout Yields Model

Curaleaf: Big Cannabis


  • Curaleaf is forecast to report a massive Q3'21 with adjusted EBITDA profits topping $100 million for the first time.
  • The company has up to 5 Northeast states opening up recreational cannabis sales by 2023, adding at least $11 billion to the market opportunity.
  • The average analyst price target predicts 125% upside in the stock.
  • The stock only trades at only 12x '22 base EBITDA targets.
  • Looking for a helping hand in the market? Members of Out Fox The Street get exclusive ideas and guidance to navigate any climate. Learn More »
As the U.S. MSOs (multi-state operators) continue to slump, the market needs to remember these companies are the true market leaders. Curaleaf (OTCPK:CURLF) is looking towards some massive quarters down the road and the market will eventually catch on. My investment thesis remains Bullish on this "Big Cannabis" play.

Read the full article on Seeking Alpha. 

Disclosure: No position mentioned. Please review the disclaimer page for more details. 


Popular posts from this blog

Aurora Cannabis: Deal Or No Deal

C3.ai: Out Of Steam (Rating Downgrade)

Archer Aviation: Promising Developments